How to predict post TAVR quality of life in “real world” patients

Despite the benefit for most patients, a small number of patients still show poor outcomes after transcatheter aortic valve implantation (TAVR). This work was able to recalibrate a previously developed risk model to predict post TAVR quality of life and provide us with a potential tool to properly estimate the chances of good recovery, or to predict futility and altogether give up the procedure.

Cortar las valvas, una medida extrema para evitar la oclusión coronaria post TAVIThe prior prediction model was developed using data from randomized clinical studies of high-risk TAVR patients. However, this model did not work well with lower risk or unselected ‘real life’ patients. The aim of this study was to optimize this risk model to better predict poor outcomes after TAVR.

 

At one year, of 13351 patients undergoing TAVR in 252 centers in the US from 2011 to 2015, 38.9% had poor outcomes; 20.7% because of death, and 18.2% because of poor or worsening quality of life.


Read also: Galileo: Rivaroxaban After TAVR Stopped Due to Early Event Rates.


This high rate has fortunately been receding: it has gone from 42% in 2012 to 37.8% in 2015 (p=0.076).

 

The original risk model based on randomized studies did not adjust well to this population of unselected patients.


Read also: Immediate Electrocardiography After TAVI, the Simplest Way to Predict Conduction Disorders.


The study recalibrated model coefficients and retested its capacity to predict poor outcomes, which improved its prediction capacity (both globally and in subgroups) reaching a C index of 0.65, and excellent calibration.

 

Conclusion

A great number of patients still show poor results after TAVR. This recalibrated prediction model at one year is far more accurate and might help us better identify TAVR candidates.

 

Original title: Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population.

Reference: Suzanne V. Arnold et al. Circ Cardiovasc Qual Outcomes. 2018;11:e004693.

 

2018-11-02-CIRCOUTCOMES


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...